12 results
8-K
EX-99.1
INBX
Inhibrx Biosciences, Inc.
13 May 21
Inhibrx Reports First Quarter 2021 Financial Results
4:05pm
of cancer and rare diseases, and we remain strongly encouraged that we will deliver on our mission.”
Financial Results
Cash and Cash Equivalents
10-K
2020 FY
INBX
Inhibrx Biosciences, Inc.
12 Mar 21
Annual report
8:46am
of individuals with proven business and scientific accomplishments and significant operating knowledge of our company.
Our Strategy
Our mission
424B4
INBX
Inhibrx Biosciences, Inc.
19 Aug 20
Prospectus supplement with pricing info
5:21pm
Healthcare Fund, L.P., Lilly Asia Ventures, WuXi Biologics (Hong Kong) Limited and Alexandria Venture Investments, among others.
Our Strategy
Our mission … others.
Our Strategy
Our mission is to discover and develop effective biologic treatments for people with life-threatening conditions and to evolve
DRS
0xa2r8btq7tb3
26 Jun 20
Draft registration statement
12:00am
S-1
d92q9
3 Jun 19
IPO registration
4:17pm
DRS/A
8zdcae9pg6cfwzqagd
22 Feb 19
Draft registration statement (amended)
12:00am
DRS
mrtrsdtcps14lzgin
7 Jan 19
Draft registration statement
12:00am
- Prev
- 1
- Next